Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Problems in general management during barbiturate therapy].

S Oda1, M Shimoda, S Yamada

  • 1Department of Neurosurgery, Tokai University School of Medicine.

No Shinkei Geka. Neurological Surgery
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlates of HIV-1 control after combination immunotherapy.

Nature·2025
Same author

Combination immunotherapy induces post-intervention control of HIV.

Research square·2025
Same author

siRNA therapy improves multimodality imaging in hereditary transthyretin cardiac amyloidosis: a case report.

QJM : monthly journal of the Association of Physicians·2024
Same author

Transcriptome mining and B cell depletion support a role for B cells in psoriasis pathophysiology.

Journal of dermatological science·2019
Same author

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.

Diabetes & metabolism·2018
Same author

Intermetallic: A Pseudoelement for Catalysis.

Accounts of chemical research·2017
Same journal

[Current State and Challenges of Digital Health in Japan].

No shinkei geka. Neurological surgery·2026
Same journal

[Emergent Surgery for Brain Tumors].

No shinkei geka. Neurological surgery·2026
Same journal

[Concepts of Cerebrospinal Fluid Management Based on a Paradigm Shift in CSF Dynamics:From the Third Circulation to the Glymphatic System and Meningeal Lymphatic Drainage].

No shinkei geka. Neurological surgery·2026
Same journal

[Management of Severe Traumatic Brain Injury].

No shinkei geka. Neurological surgery·2026
Same journal

[Management of Cerebral Vasospasm in Subarachnoid Hemorrhage].

No shinkei geka. Neurological surgery·2026
Same journal

[Perioperative Management of Spine and Spinal Cord Surgery].

No shinkei geka. Neurological surgery·2026
See all related articles

Barbiturate therapy for severe head injury and cerebrovascular disease can cause immediate complications like tachycardia and hypotension, and delayed issues such as hypokalemia and liver dysfunction. Careful monitoring is essential to manage these risks in patients undergoing barbiturate treatment.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Pharmacology

Context:

  • Investigates the safety and efficacy of barbiturate regimens in managing severe neurological conditions.
  • Focuses on patients with severe head injury or cerebrovascular disease requiring intensive treatment.
  • Examines complications associated with intravenous barbiturate administration at 1-4 mg/kg/hr.

Purpose:

  • To analyze immediate and delayed complications arising from barbiturate therapy.
  • To identify the incidence and nature of adverse events associated with barbiturate use.
  • To inform clinical practice regarding the safe administration of barbiturates.

Summary:

  • Barbiturate therapy in 63 patients with severe head injury or cerebrovascular disease revealed immediate complications: tachycardia (25%) and hypotension (22%), more frequent in surgical patients.

Related Experiment Videos

  • Delayed complications were common, including hypokalemia (65%), liver dysfunction (38%), infection (33%), cardiac failure (13%), and renal failure (2%).
  • Supportive treatments like dobutamine and dopamine were used to prevent cardiac and renal failure during barbiturate regimens.

    • Impact:

    • Highlights the significant risk of both immediate and delayed adverse events during barbiturate therapy.
    • Emphasizes the need for vigilant monitoring and proactive management strategies to mitigate barbiturate-induced complications.
    • Provides critical data for clinicians considering barbiturate regimens in neurocritical care settings.